Nice find triage. I’m posting the link below because the pay wall didn’t come up through this link.
https://www.google.com.au/amp/s/www.nytimes.com/2021/01/11/health/colonoscopy-health-home-testing.amp.html
In my opinion, ColoSTAT is a game changer when you think about it’s unique advantages over FIT or colonoscopy, and the levels of accuracy it’s achieving in trials look highly promising that it’s going to be a market leader. Massive market here and globally. Very exciting stock to be holding. Thanks for the article.
New York Times article, page-2
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.34M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 11.0¢ | $2.291K | 20.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 23335 | 3 |
View Market Depth
| Last trade - 11.54am 08/11/2024 (20 minute delay) ? |
| RHY (ASX) Chart |